What HIV post‑exposure prophylaxis and STI preventive regimen should I start after a condom break during unprotected sex one hour ago, with no symptoms, no medical history, and no current medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Management After Condom Rupture During Sex

Start HIV post-exposure prophylaxis (PEP) immediately with bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as a single daily tablet for 28 days, and arrange STI screening and hepatitis B prophylaxis. 1, 2

HIV Post-Exposure Prophylaxis (PEP)

Immediate Action Required

  • Initiate PEP now—you are within the critical 72-hour window, and every hour of delay reduces effectiveness. 3, 1, 2
  • The optimal timing is within 24 hours of exposure, and you are currently at approximately 1 hour post-exposure, which is ideal. 1, 2
  • Do not wait for HIV test results or additional information about your partner's status before starting medication. 3, 2

Recommended PEP Regimen

First-line regimen: Bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg (BIC/FTC/TAF) as a single tablet once daily. 1, 2

Alternative regimen (if BIC/FTC/TAF unavailable): Dolutegravir 50mg once daily PLUS emtricitabine/tenofovir alafenamide 200mg/25mg once daily. 1, 2

  • These integrase inhibitor-based regimens are preferred because they have superior tolerability, fewer side effects, and better completion rates compared to older regimens. 2, 4
  • The single-tablet formulation improves adherence over the 28-day course. 2

Duration and Adherence

  • Complete the full 28-day course regardless of any subsequent information you obtain about your partner's HIV status. 3, 1, 2
  • Incomplete adherence significantly reduces effectiveness—missing doses compromises protection. 2
  • Common side effects include nausea and fatigue; anti-nausea medication can be prescribed proactively to help you complete the course. 3, 2

Baseline Testing (Do Not Delay Treatment)

Perform these tests today, but start PEP first:

  • Rapid HIV antibody or antigen/antibody combination test to document your baseline HIV-negative status. 1, 2
  • Baseline testing for other sexually transmitted infections (gonorrhea, chlamydia, syphilis). 2, 5
  • Hepatitis B and C screening. 3, 1
  • Pregnancy test if applicable. 3

Follow-Up Testing Schedule

  • 4-6 weeks post-exposure: HIV antigen/antibody test PLUS HIV nucleic acid test (NAT). 1, 2
  • 12 weeks post-exposure: Laboratory-based HIV antigen/antibody combination immunoassay AND HIV nucleic acid test (NAT) for final clearance. 1, 2
  • Seek immediate medical evaluation if you develop fever, rash, sore throat, or flu-like symptoms during follow-up, as these may indicate acute HIV infection. 2

STI Prevention and Screening

Bacterial STI Prophylaxis

While the evidence focuses primarily on HIV PEP, you should also receive:

  • Screening for gonorrhea, chlamydia, and syphilis at baseline and again at 4-6 weeks. 3, 2
  • Consider empiric treatment for gonorrhea and chlamydia if your partner's STI status is unknown and you are in a high-prevalence area (discuss with your provider). 3

Hepatitis B Prophylaxis

  • If you are not vaccinated against hepatitis B, start the hepatitis B vaccine series today. 3, 5
  • If your partner is known to have hepatitis B or is at high risk, you may also need hepatitis B immunoglobulin (HBIG) in addition to vaccination. 3

Hepatitis C Screening

  • Hepatitis C testing is recommended when exposure involved blood contact or if your partner is at high risk for hepatitis C. 1
  • Repeat hepatitis C testing at follow-up visits. 3

Risk Assessment Context

Your case warrants PEP because:

  • The exposure occurred within 72 hours (you are at 1 hour, which is optimal). 3, 1, 5
  • Condom breakage during penetrative sex represents substantial risk for HIV transmission if your partner is HIV-positive or from a high-prevalence population. 3, 5
  • When your partner's HIV status is unknown, CDC guidelines recommend case-by-case evaluation, and given the substantial transmission risk from unprotected intercourse, PEP is warranted. 3, 5

Prevention Counseling and Next Steps

  • Use condoms or abstain from sex during the 28-day PEP course and 12-week follow-up period to prevent secondary transmission and reinfection. 2
  • If you anticipate ongoing high-risk exposures, discuss transitioning to pre-exposure prophylaxis (PrEP) after completing PEP and confirming HIV-negative status at 12 weeks. 3, 1, 2
  • Schedule a follow-up visit within 3-5 days to review baseline test results, assess medication side effects, and reinforce adherence. 3, 2

Critical Pitfalls to Avoid

  • Never delay PEP initiation for source testing, risk assessment, or baseline test results—start immediately. 3, 2
  • Do not stop PEP early even if you later learn your partner is HIV-negative; complete the full 28 days once started. 2
  • Do not use PEP as a substitute for ongoing prevention—if you have recurrent high-risk exposures, you need PrEP instead. 3, 5
  • Ensure you have adequate follow-up scheduled; loss to follow-up is a common failure point. 2

References

Guideline

Post-Exposure Prophylaxis for HIV Exposure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

HIV Post-Exposure Prophylaxis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Potential HIV Exposure After Condom Breakage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.